ctrl K

Watchlist Price Alert

Acrivon Therapeutics Inc.... (ACRV)

NASDAQ: ACRV · Real-Time Price · USD

1.14

0.01 (0.88%)

At close: May 14, 2025, 3:59 PM

1.17

2.63%

After-hours: May 14, 2025, 06:52 PM EDT

Acrivon Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	536K	1.09M	832K	13K
Gross Profit	n/a	-536K	-1.09M	-832K	-13K
Operating Income	-89.2M	-67.24M	-32.66M	-16.18M	-3.17M
Interest Income	9.2M	n/a	n/a	n/a	n/a
Pretax Income	-80.56M	-60.39M	-31.17M	-16.24M	-5.31M
Net Income	-80.56M	-60.39M	-29.68M	-16.24M	-5.31M
Selling & General & Admin	25.21M	21.21M	8.71M	2.47M	1.3M
Research & Development	62.99M	45.49M	23.95M	13.72M	1.87M
Other Expenses	n/a	n/a	1.49M	-59K	-2.14M
Operating Expenses	89.2M	66.7M	32.66M	16.18M	3.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	134K	n/a	n/a	n/a
Cost & Expenses	n/a	67.24M	32.66M	16.18M	3.17M
Income Tax Expense	n/a	n/a	-1.49M	-199.56K	-193.3K
Shares Outstanding (Basic)	337.92M	22.08M	21.92M	20.86M	20.86M
Shares Outstanding (Diluted)	337.92M	22.08M	21.92M	20.86M	20.86M
EPS (Basic)	-0.24	-2.74	-1.35	-0.78	-0.25
EPS (Diluted)	-0.24	-2.74	-1.35	-0.78	-0.25
EBITDA	-79.55M	-59.85M	-30.07M	-15.41M	-5.29M
EBIT	n/a	-60.39M	-31.17M	-16.24M	-5.31M
Depreciation & Amortization	n/a	536K	1.09M	832K	13K